{"url_path":"/sec/silo/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A RISK FACTORS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-056079-index.html","accession_number":"0001213900-26-056079","cik":"0001514183","ticker":"SILO","issuer_name":"Silo Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1514183/0001213900-26-056079-index.html","primary_entity_key":"0001514183","primary_entity_name":"Silo Pharma, Inc."},"word_count":154,"has_tables":true,"body_markdown":"**ITEM 1A. RISK FACTORS**\n\n \n\nRisk factors that affect our business and financial\nresults are discussed in Part I, Item 1A “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31,\n2025 as filed with the SEC on March 27, 2026 (“Annual Report”). Except as set forth below, there have been no material changes\nin our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks described in our Annual\nReport, which could materially affect our business, financial condition or future results. The risks described in our Annual Report are\nnot the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also\nmay materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business,\nfinancial condition, and/or results of operations could be negatively affected."}